MDT

96.23

+0.61%↑

VEEV

289.2

+0.83%↑

A

139.55

+0.4%↑

HQY

95.33

+2.34%↑

PHR.US

22.98

+4.41%↑

MDT

96.23

+0.61%↑

VEEV

289.2

+0.83%↑

A

139.55

+0.4%↑

HQY

95.33

+2.34%↑

PHR.US

22.98

+4.41%↑

MDT

96.23

+0.61%↑

VEEV

289.2

+0.83%↑

A

139.55

+0.4%↑

HQY

95.33

+2.34%↑

PHR.US

22.98

+4.41%↑

MDT

96.23

+0.61%↑

VEEV

289.2

+0.83%↑

A

139.55

+0.4%↑

HQY

95.33

+2.34%↑

PHR.US

22.98

+4.41%↑

MDT

96.23

+0.61%↑

VEEV

289.2

+0.83%↑

A

139.55

+0.4%↑

HQY

95.33

+2.34%↑

PHR.US

22.98

+4.41%↑

Search

West Pharmaceutical Services Inc

Abierto

SectorSanidad

261.89 -0.52

Resumen

Variación precio

24h

Actual

Mínimo

258.82

Máximo

262.99

Métricas clave

By Trading Economics

Ingresos

42M

132M

Ventas

68M

766M

P/B

Media del Sector

40.19

37.257

Rentabilidad por dividendo

0.3

Margen de beneficios

17.202

Empleados

10,600

EBITDA

48M

199M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+23.01% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.30%

2.94%

Próximas Ganancias

23 oct 2025

Fecha Próximo Dividendo

19 nov 2025

Próxima Fecha de Ex Dividendo

12 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

4.2B

19B

Apertura anterior

262.41

Cierre anterior

261.89

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

172 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

West Pharmaceutical Services Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 oct 2025, 21:45 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13 oct 2025, 21:07 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13 oct 2025, 17:03 UTC

Principales Movimientos del Mercado

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13 oct 2025, 23:53 UTC

Charlas de Mercado

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13 oct 2025, 23:39 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13 oct 2025, 21:57 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13 oct 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13 oct 2025, 21:06 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 20:52 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13 oct 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

13 oct 2025, 20:35 UTC

Adquisiciones, fusiones, absorciones

Goldman Expects to Close Deal in 1Q

13 oct 2025, 20:34 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13 oct 2025, 20:33 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Currently Manages $7B of Assets Under Supervision

13 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13 oct 2025, 20:29 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Buy VC Firm Industry Ventures

13 oct 2025, 19:05 UTC

Charlas de Mercado

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13 oct 2025, 18:59 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13 oct 2025, 18:26 UTC

Charlas de Mercado

Precious Metals Close at New Record Highs -- Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13 oct 2025, 16:03 UTC

Adquisiciones, fusiones, absorciones

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13 oct 2025, 15:35 UTC

Charlas de Mercado

Precious Metals Push Record Highs Further -- Market Talk

Comparación entre iguales

Cambio de precio

West Pharmaceutical Services Inc previsión

Precio Objetivo

By TipRanks

23.01% repunte

Estimación a 12 Meses

Media 322 USD  23.01%

Máximo 350 USD

Mínimo 275 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para West Pharmaceutical Services Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

8

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

213.26 / 219.27Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

172 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat